Executive Decision-Making and Strategy: The Adoption Timeline Everyone Trusts — And Why Procurement Behavior Consistently Diverges From It The published forecast is not wrong because it lies. It is wrong because it measures intention instead of budget. A capacity expansion decision worth $47M does not get built on a hunch...
Why Primary Research Is More Valuable in the AI Age, Not Less | Consainsights Market Intelligence · Primary Research · September 2026 AI gave every organisation access to the same market intelligence, in the same seconds, from the same sources. That did not solve the market research problem. It created a new one...
In this guide, you will learn how to conduct effective market research for a healthcare product launch. It explains how to set clear objectives, understand stakeholders, analyze the market, collect reliable data, and use insights to plan a strong go-to-market strategy. Each step helps you reduce risk, meet compliance needs, and increase product adoption with clear, data-backed decisions...
In financial institutions, market research is the foundation for making informed business decisions. For banks, NBFCs, fintech startups, and investment firms, it helps identify customer needs, industry gaps, and the right opportunities for innovation. It involves collecting and analyzing data about customers, competitors, products, and market trends...
Market research is the foundation of smart product development. It helps you understand your customers, market gaps, and competitor strategies before investing time or money. In this guide, you will learn step by step how to do market research for product development...
Market research in retail and eCommerce means collecting, analyzing, and using data to make better business decisions. It helps retailers and online sellers understand their customers, spot trends, compare competitors, and reduce risks. In fast-moving digital markets, doing good market research is no longer optional; it is essential...
Biosimilars are medicines that are very close to already approved biologic drugs. They are not exact copies, but they work in the same way and are proven safe and effective. Because they cost less than original biologics, biosimilars help reduce healthcare spending and allow more patients to get access to important treatments...
Strategies for Successful Pharma Product Launches Launching a new pharma product is not easy. It takes years of research, large investments, and strict regulatory approvals. Even after approval, many products fail because they do not reach doctors, patients, or payers in the right way...
As of 2024, the global AI in Mental Health market is valued at approximately $2.1 billion, with an impressive CAGR of 7.8%. This growth reflects a rising demand for scalable, technology-driven solutions in an area where access to care remains deeply uneven. Despite rapid advancements in digital health, the world continues to face a mental health crisis with more than 970 million people worldwide living with mental health disorders, a shortage of qualified professionals, and significant barriers related to cost, stigma, and availability of treatment...
Health equity means everyone gets the care they need to live a healthy life. It means care and medicines reach people no matter their race, age, money, or where they live. Right now, many people do not get fair care...
Accurate drug demand forecasting is the key to keeping medicines available and avoiding waste. It helps companies plan production, manage supply chains, and meet patient needs on time. The future of drug demand is shaped by many factors, such as aging populations, new diseases, patent expiries, and personalized medicine...
Beyond Air, Inc. (NASDAQ: XAIR) has submitted a premarket approval (PMA) supplement to the U.S. Food and Drug Administration (FDA) for its second-generation LungFit PH II system...
The U.S. Food and Drug Administration (FDA) has approved BRINSUPRI™ (brensocatib), making it the first and only therapy for non-cystic fibrosis bronchiectasis (NCFB). This chronic lung disease affects more than 500,000 people in the United States and has long been without an approved treatment option...
Cell and gene therapies (CGTs) represent a new frontier in healthcare. These treatments aim to modify or replace cells and genes to treat or cure diseases that were previously untreatable. While their promise is enormous, launching them is not simple...
Running oncology clinical trials in the US is complex and resource-heavy. Patient recruitment, biomarker testing, data collection, and regulatory reporting all demand specialized expertise. Pharmaceutical companies and biotech sponsors often rely on Contract Research Organizations (CROs) to manage parts or all of the trial process...
Regulation shapes every part of the pharmaceutical industry. Agencies like the WHO, FDA (US), EMA (EU), MHRA (UK), ANVISA (Brazil), NMPA (China), and CDSCO (India) control how drugs are researched, developed, manufactured, and approved. In 2025, these authorities are updating their frameworks to keep pace with artificial intelligence, digital health, advanced clinical trial models, sustainability rules, and global supply chain standards...
Pharma companies spend billions every year trying to influence doctors, patients, and healthcare systems. Yet clinical data and product claims alone often fail to change outcomes. People rely on habits, emotions, social cues, and mental shortcuts, not just logic...
Vaccines are biological products that protect people from infectious diseases by stimulating the body’s immune system. They are one of the most effective tools in public health, reducing illness, saving lives, and lowering healthcare costs. The demand for vaccines is increasing worldwide due to government immunization programs, new biotechnology platforms like mRNA, and a growing need to prevent both infectious and chronic diseases...
Pharma R&D efficiency is under constant review by executives, investors, and regulators. The cost of bringing a new drug to market has increased, while success rates in clinical trials remain low. At the same time, pressure from pricing reforms, patent expiries, and investor expectations is forcing companies to do more with less...
Cell and gene therapies are changing modern medicine, offering new hope for patients with cancer, genetic disorders, and rare diseases. However, the success of these treatments depends on reliable and scalable manufacturing. Current processes are often complex, slow, and dependent on manual steps that introduce risks...
